Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection
Top Cited Papers
Open Access
- 20 February 2003
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 348 (8), 702-710
- https://doi.org/10.1056/nejmoa022048
Abstract
Metabolic abnormalities associated with human immunodeficiency virus (HIV) infection, including dysglycemia and hyperlipidemia, are increasingly prevalent, and there is concern about the possibility of an association with accelerated cardiovascular and cerebrovascular disease.Keywords
This publication has 21 references indexed in Scilit:
- Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment databaseAIDS, 2001
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Vascular complications associated with use of HIV protease inhibitorsThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionThe New England Journal of Medicine, 1998
- In Vitro Insulin-Like Growth Factor-I, Growth Hormone, and Insulin Resistance Occurs in Symptomatic Human Immunodeficiency Virus-1–Infected ChildrenPediatric Research, 1993
- Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndromeJournal of Clinical Endocrinology & Metabolism, 1992
- Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected menMetabolism, 1991
- Hypertriglyceridemia in the acquired immunodeficiency syndromeAmerican Journal Of Medicine, 1989